HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

BIM 23023

a somatostatin receptor ligand

Also Known As:

BIM-23023; BIM23023

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - BIM 23023: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - BIM 23023: 1

Experts

1.	Culler, Michael D: 1 article (11/2003)
2.	Dong, Josse: 1 article (11/2003)
3.	Kim, Sun: 1 article (11/2003)
4.	Melmed, Shlomo: 1 article (11/2003)
5.	Moreau, Jacques-Pierre: 1 article (11/2003)
6.	Ren, Song-Guang: 1 article (11/2003)
7.	Taylor, John: 1 article (11/2003)

Related Diseases

1.	Pituitary Neoplasms (Pituitary Adenoma) 11/01/2003 - "The selective SSTR2 agonist, BIM-23023 (50% effective dose, 0.42), and the DAR2 agonist, BIM-53097 (50% effective dose, 22.1), dose- dependently inhibited GH secretion in cultured primary rat and human fetal as well as in human pituitary tumor cells derived from GH-secreting adenomas. "
2.	Adenoma (Adenomas) 11/01/2003 - "The selective SSTR2 agonist, BIM-23023 (50% effective dose, 0.42), and the DAR2 agonist, BIM-53097 (50% effective dose, 22.1), dose- dependently inhibited GH secretion in cultured primary rat and human fetal as well as in human pituitary tumor cells derived from GH-secreting adenomas. "